Vicapsys Life Sciences, Inc.

OTC:VICP

2 (USD) • At close November 9, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720092008
Operating Activities:
Net Income -1.182-0.985-0.237-0.766-1.034-1.285-3.234-1.67-2.438
Depreciation & Amortization 0.1150.0310.0310.0310.0310.1270.1790.1220.129
Deferred Income Tax 0000.2640000.0020.013
Stock Based Compensation 0.0210.1060.0040.0150.11900.4690.2370.157
Change In Working Capital 0.6290.269-0.1430.4570.047-0.068-0.575-0.2080.483
Accounts Receivables 0000000-0.673-0.438
Inventory 000000000
Accounts Payables 0.5920.271-0.1370.3410.047-0.084-0.611.2180.61
Other Working Capital 0.037-0.002-0.0050.11500.2930.035-0.2080.483
Other Non Cash Items 0.1150.34-0.1-0.264-0.133-0.5251.4380.1220.059
Operating Cash Flow -0.418-0.238-0.444-0.263-0.97-2.089-3.161-1.394-1.596
Investing Activities:
Investments In Property Plant And Equipment 0-00000-0.004-0.075-0.117
Acquisitions Net 000.100000.0090.106
Purchases Of Investments 000000000
Sales Maturities Of Investments 000.1000000
Other Investing Activites 00-0.100-0.038-0.0370.0090.106
Investing Cash Flow 000.100-0.038-0.041-0.066-0.011
Financing Activities:
Debt Repayment 0.2620000001.5170.424
Common Stock Issued 0.10.0350.5600.9721.4893.6801.191
Common Stock Repurchased 000000000
Dividends Paid 000000000
Other Financing Activities 0.050.035000.1771.6653.6800
Financing Cash Flow 0.4130.0350.5601.1481.6653.681.5171.615
Other Information:
Effect Of Forex Changes On Cash 000000000
Net Change In Cash -0.005-0.2030.216-0.2630.178-0.4610.4260.0570.008
Cash At End Of Period 0.0090.0140.2170.0010.2640.0860.5480.1220.065